John Treanor

Credentials: · ·

History

Preclinical Development Services for AIDS Therapeutics
National Institute of Allergy and Infectious Diseases · N01
Contact PI · $37.6M · Sri International
2014–2022
Centers of Excellence for Influenza Research and Surveillance
National Institute of Allergy and Infectious Diseases · N01
Contact PI · $22.2M · University of Rochester
2007–2014
Estimates of Influenza Vaccine Effectiveness
NCIRD · U18
Contact PI · $3.3M · University of Rochester
2008–2012
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $1.4M · University of Rochester
1997–2006

Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease
Principal investigator · Terminated · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2016
Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine
Principal investigator · Completed · Phase 1
International AIDS Vaccine Initiative
2015–2016
Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years Old
Principal investigator · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2014
Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults
Principal investigator · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2013